GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.The rebrand comes after GSK transferred its consumer health business to Haleon to focus on ...

With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare ...

GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya Limited. Haleon ...

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...

GSK previously came under pressure from activists Elliott Investment Management and Bluebell Capital Partners. While both broadly agreed with the company’s plans to spin off its consumer-health ...

GSK Plc is a long-term underperformer among ... Shares in the British drugmaker have fallen about 19% since it spun off its consumer health business in 2022, a move that activists had supported.

Hongkong & Shanghai Banking Corporation Ltd. ICICI Bank Ltd. Market Crashes For 5-Sessions In Row: Why Sensex Fell 817 Pts And Nifty Dipped 248 Pts On Monday, February 24? Stock Market Live ...

February 27, 2025 GSK abandons diversity targets following ... says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit ...